{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Chamberlain AT"],"funding":["National Institute of Allergy and Infectious Diseases","Center for AIDS Research at Emory University","NIAID NIH HHS","Emory Covid-19 Response Collaborative","California Department of Health"],"pagination":["396-403"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8807152"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["225(3)"],"pubmed_abstract":["<h4>Background</h4>Reported coronavirus disease 2019 (COVID-19) cases underestimate true severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Data on all infections, including asymptomatic infections, are needed. To minimize biases in estimates from reported cases and seroprevalence surveys, we conducted a household-based probability survey and estimated cumulative incidence of SARS-CoV-2 infections adjusted for antibody waning.<h4>Methods</h4>From August to December 2020, we mailed specimen collection kits (nasal swabs and blood spots) to a random sample of Georgia addresses. One household adult completed a survey and returned specimens for virus and antibody testing. We estimated cumulative incidence of SARS-CoV-2 infections adjusted for waning antibodies, reported fr"],"journal":["The Journal of infectious diseases"],"pubmed_title":["Cumulative Incidence of SARS-CoV-2 Infections Among Adults in Georgia, United States, August to December 2020."],"pmcid":["PMC8807152"],"funding_grant_id":["R01 AI143875","P30AI050409","3R01AI143875-02S1"],"pubmed_authors":["Siegler AJ","Sullivan PS","Chamberlain AT","Shioda K","Hall EW","Fahimi M","Lopman BA","Sanchez T","Bradley H","Drenzek C","Luisi N","Toomey KE"],"additional_accession":[]},"is_claimable":false,"name":"Cumulative Incidence of SARS-CoV-2 Infections Among Adults in Georgia, United States, August to December 2020.","description":"<h4>Background</h4>Reported coronavirus disease 2019 (COVID-19) cases underestimate true severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Data on all infections, including asymptomatic infections, are needed. To minimize biases in estimates from reported cases and seroprevalence surveys, we conducted a household-based probability survey and estimated cumulative incidence of SARS-CoV-2 infections adjusted for antibody waning.<h4>Methods</h4>From August to December 2020, we mailed specimen collection kits (nasal swabs and blood spots) to a random sample of Georgia addresses. One household adult completed a survey and returned specimens for virus and antibody testing. We estimated cumulative incidence of SARS-CoV-2 infections adjusted for waning antibodies, reported fr","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Feb","modification":"2026-05-08T10:36:00.725Z","creation":"2025-02-19T01:47:04.046Z"},"accession":"S-EPMC8807152","cross_references":{"pubmed":["34662409"],"doi":["10.1093/infdis/jiab522"]}}